
Charles Marmar
Director, PTSD Research Program · NYU Grossman School of Medicine
Credentials: · · ·
History
PresentPTSD Research Program · NYU Grossman School of Medicine
PresentDepartment of Psychiatry · NYU Grossman School of Medicine

- 1972–1976
- 1966–1970
Research
Psychotherapy for Military-Related PTSD: A Review of Randomized Clinical Trials
Review · JAMA · 2015 · Last of 4 authors · 687 citations
Archives of Internal Medicine · 2007 · Last of 5 authors · 657 citations
Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)
Journal of Traumatic Stress · 1998 · 621 citations

70 papers
- OW
29 papers
- KR
19 papers
- SI
17 papers
- LB
16 papers
- VR
Victor Reus
15 papers
- SM
14 papers
- FS
12 papers
Grants
- 2026–2031
Mechanistic Insights into Topiramate Response in Comorbid AUD and PTSD: From Patients to Cells
National Institute on Alcohol Abuse and Alcoholism · R01
PI · $433.1K · Mayo Clinic Rochester
- 2025–2029
A Translational Approach for Novel Precision Medicine Models
National Institute on Alcohol Abuse and Alcoholism · R01
PI · $3.2M · New York University School of Medicine
- 2018–2025
Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid with PTSD
National Institute on Alcohol Abuse and Alcoholism · P01
Contact PI · $6.4M · New York University School of Medicine
- 2022–2025
Leveraging Systems Pharmacology to Advance Precision Medicine for Gabapentin Treatment of AUD
National Institute on Alcohol Abuse and Alcoholism · R01
Contact PI · $1.7M · New York University School of Medicine
Clinical trials
- 2021–2026
Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI
Principal investigator · Recruiting · Phase 2
NYU Langone Health
- 2020–2021
Principal investigator · Withdrawn
NYU Langone Health
- 2019–2025
Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD
Principal investigator · Recruiting · Phase 2
NYU Langone Health
- 2019–2022
Cannabidiol as a Treatment for AUD Comorbid With PTSD
Principal investigator · Completed · Phase 1, Phase 2
NYU Langone Health


